Robert Chew

555 total citations
8 papers, 438 citations indexed

About

Robert Chew is a scholar working on Pharmacology, Rheumatology and Molecular Biology. According to data from OpenAlex, Robert Chew has authored 8 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in Robert Chew's work include Rheumatoid Arthritis Research and Therapies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Robert Chew is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Robert Chew collaborates with scholars based in United States, South Korea and South Africa. Robert Chew's co-authors include Richard J. Riese, Thomas T. Kawabata, Sriram Krishnaswami, Eric M. Mortensen, Kevin Winthrop, Hernán Valdez, Hisashi Yamanaka, Larry D. Altstiel, Clare B. Billing and Wendy F. Davidson and has published in prestigious journals such as Annals of the Rheumatic Diseases, Obesity and Breast Cancer Research and Treatment.

In The Last Decade

Robert Chew

8 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Chew United States	6	196	90	86	77	76	8	438
Yasuaki Okuda Japan	13	188 1.0×	70 0.8×	105 1.2×	19 0.2×	71 0.9×	26	572
Julia Katzenbeisser Germany	6	189 1.0×	63 0.7×	72 0.8×	42 0.5×	19 0.3×	7	509
R. Furie United States	6	128 0.7×	67 0.7×	61 0.7×	23 0.3×	18 0.2×	11	442
Eric Mukherjee United States	11	109 0.6×	37 0.4×	25 0.3×	49 0.6×	21 0.3×	17	411
Kathleen Kunke United States	12	69 0.4×	71 0.8×	34 0.4×	39 0.5×	63 0.8×	15	584
Keystone Ec Canada	10	96 0.5×	48 0.5×	62 0.7×	18 0.2×	50 0.7×	15	359
Veronika Lang Germany	10	60 0.3×	70 0.8×	43 0.5×	15 0.2×	61 0.8×	14	494
Katsue Sunahori Japan	10	203 1.0×	93 1.0×	37 0.4×	37 0.5×	28 0.4×	10	647
Riccardo Terenzi Italy	11	186 0.9×	45 0.5×	58 0.7×	33 0.4×	24 0.3×	23	393
Eun‐Heui Jin South Korea	11	94 0.5×	67 0.7×	14 0.2×	27 0.4×	21 0.3×	25	394

Countries citing papers authored by Robert Chew

Since Specialization

Citations

This map shows the geographic impact of Robert Chew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Chew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Chew more than expected).

Fields of papers citing papers by Robert Chew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Chew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Chew. The network helps show where Robert Chew may publish in the future.

Co-authorship network of co-authors of Robert Chew

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Chew. A scholar is included among the top collaborators of Robert Chew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Chew. Robert Chew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Delahanty, Linda M., et al.. (2016). Maximizing retention in long‐term clinical trials of a weight loss agent: use of a dietitian support team. Obesity Science & Practice. 2(3). 256–265. 11 indexed citations

2.

Schwam, Elias, Timothy Nicholas, Robert Chew, et al.. (2014). A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer’s Disease. Current Alzheimer Research. 11(5). 413–421. 64 indexed citations

3.

Winthrop, Kevin, Hisashi Yamanaka, Hernán Valdez, et al.. (2014). Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology. 66(10). 2675–2684. 273 indexed citations

4.

Mariette, Xavier, Jeffrey R. Curtis, Richard J. Riese, et al.. (2012). THU0131 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analysis of malignancies across the rheumatoid arthritis clinical programme. Annals of the Rheumatic Diseases. 71. 199–199. 9 indexed citations

5.

Curtis, Jeffrey R., Richard J. Riese, Carol A. Connell, et al.. (2012). THU0140 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analysis of gastrointestinal adverse events across the rheumatoid arthritis clinical programme. Annals of the Rheumatic Diseases. 71. 202–203. 4 indexed citations

6.

Aronne, Louis J., Nick Finer, Priscilla Hollander, et al.. (2011). Efficacy and Safety of CP‐945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance. Obesity. 19(7). 1404–1414. 25 indexed citations

7.

Schwam, Elias, Rebecca M. Evans, Timothy Nicholas, et al.. (2011). O4‐06‐05: PF‐04447943: A phase II controlled clinical trial of a selective PDE9A inhbitor in Alzheimer's disease. Alzheimer s & Dementia. 7(4S_Part_20). 2 indexed citations

8.

Buzdar, Aman U., Daniel F. Hayes, Shunchao Yan, et al.. (2002). Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer. Breast Cancer Research and Treatment. 73(2). 161–175. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact